News
Elliott Management Says Goodyear Tire Worth At Least $21 a Share
The Goodyear Tire and Rubber Company (NYSE: GT) stock has been choppy between $9.66 and $12.50 until the last seven months when activist investor Elliott Management called out the board of
It’s Time To Try On VF Corporation’s 6% Yield
VF Corporation (NYSE: VFC) has entered a year of change that could lead the stock higher. The company is working to turn around the core brand, Vans, and improve its supply chain and efficiency
monday.com Surges on Price and Volume after Blowout Results
monday.com Ltd. (NASDAQ: MNDY) provides workflow collaboration and customer relationship management (CRM) software applications used by over 180,000 companies. monday.com is used by 59% of the
Is PulteGroup Overbought After Double-Digit Gains?
Contrary to doom and gloom coming from some market prognosticators, residential home builders have been a highly investable industry in 2023. Recently, PulteGroup Inc. (NYSE: PHM) has been the
Is This Why Mike Burry Took a Stake in The RealReal Stock?
Luxury consignment resale platform The RealReal Inc. (NASDAQ: REAL) shares have been sinking from $30.22 in February 2021 to a low of $1.00 in March 2023. However, an unlikely buyer has been
Hunting For A Deal? Ross Stores May Just Be It
Despite a choppy United States financial market, where investors are still digesting the aftermath of the FED raising rates in its attempt to control inflation, shares of Ross Stores (NASDAQ:
It’s Time To Take Another Bite Of Take-Two Interactive
Take-Two Interactive (NASDAQ: TTWO) had a mixed quarter and gave weak guidance, but the stock is up strongly despite the news. The report was mixed but came with a growth outlook that told the
Analysts Say These 2 Mid-Cap Biotechs Have 2x Potential
On May 15th, mid-cap biotechnology company Sarepta Therapeutics was the big winner in an otherwise quiet day for the Russell 1000 Index. Sarepta jumped more than 30% after an FDA advisory panel
German International School of Silicon Valley wird für innovatives KI-Projekt mit hochdotiertem Preis der Deutschen Industrie- und Handelskammer (IHK) ausgezeichnet
MOUNTAIN VIEW und SAN FRANCISCO, KALIFORNIEN / ACCESSWIRE / 11. Mai 2023 / Die German International School of Silicon Valley (GISSV) wurde im Rahmen des von der Deutschen Industrie- und
Don’t Know What Stocks to Buy in the Oil Market? Try the XLE ETF
If you've been keeping track of oil prices, especially since OPEC cut production by an additional 1.16 million barrels daily, you might be searching for ways to invest in the oil market. There are
PacWest, First Horizon Shares Plummet On Continued Bank Worries
That collective sigh of relief you heard when JPMorgan Chase & Co. (NYSE: JPM) purchased the assets of First Republic Bank has morphed into panic. Another regional bank, PacWest Bancorp (NASDAQ:
3 Underperforming Nasdaq 100 Stocks Worth a Closer Look
A simple yet logical investing strategy is to wholeheartedly embrace an index’s biggest losers for their collective rebound potential.
The most common example is buying shares of the 10 highest
Loews Is The Insurance Company That Diversified Correctly
Insurance companies like Progressive (NYSE: PGR), Allstate Insurance (NYSE: ALL), and even American International Group (NYSE: AIG) are, by their very nature, heavily dependent on the volumes of
Rollins Pest Control Needs to be in Your Watchlist
You probably see those pest control vehicles rolling through your neighborhood on a regular basis, but it’s almost certain you didn’t realize there might be an investment opportunity there.
A Top Is In For McDonald’s Corporation Stock
McDonald’s (NYSE: MCD) Q1 results are respectable and drove the stock to a new all-time high, but this is a top for it and perhaps the fast-food industry that could impact pricing action the rest
Can High-Yield Whirlpool Spin Higher In 2023?
Whirlpool Corporation (NYSE: WHR) is not an exciting name, it isn’t a growth stock, and it has headwinds in the form of slowing home sales, but it is also an attractive investment. This blue-chip
Buying the Dip On Albemarle, Fundamentals Still Sound
Certain mining stocks are falling after the Chilean government announced its plan to change the nation's stance toward the mining industry, rightfully worrying most investors. Chile has delivered
Moderna: Europäische Arzneimittelagentur erteilt für MRNA-4157/V940, einen personalisierten MRNA-Prüfimpfstoff gegen Krebs, in Kombination mit Keytruda(R) (Pembrolizumab) den Status eines prioritären Arzneimittels (PRIME) für die adjuvante Behandlung
Europäische Arzneimittelagentur erteilt für MRNA-4157/V940, einen personalisierten MRNA-Prüfimpfstoff gegen Krebs, in Kombination mit Keytruda(R) (Pembrolizumab) den Status eines prioritären
Moderna: MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for Adjuvant Treatment of Patients With High-Risk Stag
MRNA-4157/V940, an Investigational Personalized MRNA Cancer Vaccine, in Combination With Keytruda(R) (Pembrolizumab), Receives Prime Scheme Designation From the European Medicines Agency for
Moderna Finalizes Agreement with the Government of the Republic of Kenya to Establish an mRNA Manufacturing Facility
- Facility to enable access to manufactured mRNA vaccines for Kenya and the African continent, providing health security and building upon Moderna's global public health commitments
Moderna finalisiert Abkommen mit Regierung von Republik Kenia hinsichtlich Errichtung von mRNA-Fertigungsanlage
- Anlage soll Kenia und afrikanischem Kontinent Zugang zu mRNA-Impfstoffen verschaffen, Gesundheitssicherheit gewährleisten und auf globalem Engagement von Moderna in Bereich von
Chantal Friebertshäuser Joins Moderna as Senior Vice President, Commercial
Newly created role will have responsibility for commercial efforts in Europe, Middle East and Canada
CAMBRIDGE, MA / ACCESSWIRE / December 20, 2022 / Moderna, Inc. (NASDAQ:MRNA), a
Chantal Friebertshäuser zu Senior Vice President, Commercial von Moderna ernannt
Neu geschaffene Position wird für kommerzielle Bestrebungen in Europa, Nahen Osten und Kanada verantwortlich sein
Cambridge (Massachusetts) / Accesswire / 20. Dezember 2022 / Moderna Inc.
Der Ausschuss für Humanarzneimittel (CHMP) der EMA empfiehlt die Anwendung von BA.1 Targeting Bivalent-COVID-19-Auffrischimpfung von Moderna bei Kindern (6–11 Jahre) in der Europäischen Union
Die Empfehlung stützt sich auf klinische Daten zum bivalenten auf Omikron zugeschnittenen COVID-19-Impfstoff von Moderna, mRNA.1273.214
Die an die Omikron-Virusvarianten angepassten
EMA Committee for Medicinal Products for Human Use (CHMP) Recommends the Use of Moderna’s BA.1 Targeting Bivalent COVID-19 Booster in Children (6-11 Years) In the European Union
The recommendation is based on clinical data for Moderna's bivalent Omicron-targeting COVID-19 vaccine, mRNA.1273.214
Moderna's bivalent Omicron-targeting COVID-19 vaccines (mRNA.1273.214